Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Clinical trial NCT04530565 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT04530565

Sponsor

National Cancer Institute (NCI)

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2021-01-25

Primary completion

2028-07-01

Enrollment

348

View on ClinicalTrials.gov